[Contribution of new drugs to the better control of epilepsy].
Herranz Fernández
J L
JL
Neuropediatría Hospital Universitario M. Valdecilla, Santander.
D000614:Aminocaproates / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy*; D000078328:Felbamate; D006801:Humans; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D003692:Delayed-Action Preparations; D048448:Phenylcarbamates; D011409:Propylene Glycols; D014635:Valproic Acid; D020888:Vigabatrin; D000078328:Felbamate
Aportación de los nuevos fármacos al mejor control de las epilepsias.